Work

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(03)14287-0

Authors: Lars Wallentin, Robert G Wilcox, W Douglas Weaver, Håkan Emanuelsson, Andrew Goodvin, Per Nyström, Anders Bylock

Institutions: Uppsala University, Uppsala University Hospital, Nottingham University Hospitals NHS Trust, Henry Ford Hospital, AstraZeneca (United Kingdom), AstraZeneca (Sweden)

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca

OpenAlex ID: W2121366426

FWCI: 32.51

Cites: 31

Cited by: 365

Related to: 10